Comet H1 2026 Results Overview
Comet reported first‑half 2026 group sales of CHF240 million, reflecting a reported year‑over‑year increase of 5.6% and an organic growth rate of 12.7%. The sales figure matched UBS’s internal estimate of CHF239 million but was slightly below the consensus expectation of CHF244 million.
Reported EBITDA for the period was CHF31 million, delivering a margin of 13.1%, which exceeded the consensus estimate of CHF28 million. Net income rose to CHF14 million, a 72% increase year‑over‑year, although the result was partially offset by higher tax expenses.
Second‑quarter group orders amounted to CHF213 million, surpassing UBS’s estimate of CHF206 million, and the group’s book‑to‑bill ratio stood at 1.57.
Segment performance:
- PCT generated CHF144 million in sales, up 7.0% year‑over‑year, with an EBITDA margin of 20.1%.
- IXS recorded CHF49 million in sales, showing flat year‑over‑year growth and an EBITDA margin of –8.2%.
- IXM delivered CHF54 million in sales, growing 10.5% year‑over‑year, with an EBITDA margin of 16.1%.
For fiscal year 2026, Comet provided quantitative guidance of CHF540 million to CHF570 million in sales and a reported EBITDA margin range of 14.0% to 17.0%, which includes a one‑off adjustment of three percentage points. The company previously indicated that both net sales and adjusted EBITDA margin for 2026 would exceed 2025 levels. Consensus forecasts for FY2026 anticipate sales of CHF560 million and a reported EBITDA margin of 15.2%.